P. Sladkevicius
YOU?
Author Swipe
View article: Comparison of sociodemographic factors, lifestyle, and gastrointestinal symptoms between patients with endometriosis and IBS
Comparison of sociodemographic factors, lifestyle, and gastrointestinal symptoms between patients with endometriosis and IBS Open
View article: Cumulative live birth rates under three consecutive IVF/ICSI treatment cycles are reduced in women with endometriosis and/or adenomyosis diagnosed by ultrasonography
Cumulative live birth rates under three consecutive IVF/ICSI treatment cycles are reduced in women with endometriosis and/or adenomyosis diagnosed by ultrasonography Open
STUDY QUESTION Does endometriosis and/or adenomyosis, diagnosed using the International Deep Endometriosis Analysis (IDEA) group and the Morphological Uterus Sonographic Assessment (MUSA) group revised definitions, impact cumulative live b…
View article: Imaging in gynecological disease (28): clinical and ultrasound characteristics of serous and mucinous cystadenomas in the adnexa
Imaging in gynecological disease (28): clinical and ultrasound characteristics of serous and mucinous cystadenomas in the adnexa Open
Objective To describe the clinical and ultrasound characteristics of serous and mucinous cystadenomas in the adnexa. Methods This was a retrospective international multicenter study. Using the International Ovarian Tumor Analysis (IOTA) da…
View article: The health profile of Lithuanian beekeepers and use of bee products for health purposes
The health profile of Lithuanian beekeepers and use of bee products for health purposes Open
Background There is little research about the health profile and attitude of beekeepers themselves who are the main suppliers of apitherapy products to the general public. The study aims to describe the health profile of Lithuanian bee kee…
View article: Correlation of adenomyosis features to live birth rates after the first <scp>IVF</scp>/<scp>ICSI</scp> treatment, when using the revised Morphological Uterus Sonographic Assessment group definitions
Correlation of adenomyosis features to live birth rates after the first <span>IVF</span>/<span>ICSI</span> treatment, when using the revised Morphological Uterus Sonographic Assessment group definitions Open
Introduction Data regarding the impact of adenomyosis on the outcomes after in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) treatment are conflicting. Standardized diagnostic criteria are prerequisites for studying …
View article: Morphological changes of endometriomas during pregnancy and after delivery detected using ultrasound
Morphological changes of endometriomas during pregnancy and after delivery detected using ultrasound Open
Three out of four endometriomas undergo morphological changes during pregnancy. Decidualized endometrioma may mimic borderline malignancy, however, changes regress after delivery. Knowing the natural behavior of endometriomas during pregna…
View article: Evaluating the development of endometriosis and adenomyosis lesions over time: An ultrasound study of symptomatic women
Evaluating the development of endometriosis and adenomyosis lesions over time: An ultrasound study of symptomatic women Open
Introduction There is a gap in knowledge regarding development of endometriosis and adenomyosis lesions visible at transvaginal ultrasound. The objectives were to evaluate if women with symptoms suggestive of endometriosis or adenomyosis b…
View article: Prevalence of adenomyosis features in women scheduled for assisted reproductive treatment, using the Morphological Uterus Sonographic Assessment group definitions
Prevalence of adenomyosis features in women scheduled for assisted reproductive treatment, using the Morphological Uterus Sonographic Assessment group definitions Open
Introduction Studies that use standardized ultrasonographic criteria to diagnose adenomyosis in subfertile women are needed. These would improve the understanding of the disease burden and enable further studies on its impact on fertility …
View article: Endometriosis diagnosed by ultrasound is associated with lower live birth rates in women undergoing their first in vitro fertilization/intracytoplasmic sperm injection treatment
Endometriosis diagnosed by ultrasound is associated with lower live birth rates in women undergoing their first in vitro fertilization/intracytoplasmic sperm injection treatment Open
The presence of DIE and/or endometrioma diagnosed by TVUS lowers the chance of live birth in women undergoing their first IVF/ICSI treatment.
View article: EP26.08: Imaging in gynecological disease: clinical and ultrasound characteristics of uterine malignant mixed Müllerian tumours
EP26.08: Imaging in gynecological disease: clinical and ultrasound characteristics of uterine malignant mixed Müllerian tumours Open
Objectives: ACUM or ''Accessory Cavitated Uterine Malformation'' is a relatively rare and recently recognised uterine abnormality.It has been defined as a non-communicating accessory uterine cavity with functional endometrium, located at t…
View article: EP31.05: Development of endometriosis and adenomyosis at long‐term follow‐up of women without abnormal findings at initial ultrasound examination
EP31.05: Development of endometriosis and adenomyosis at long‐term follow‐up of women without abnormal findings at initial ultrasound examination Open
Objectives: Investigate if women with symptoms suggestive of endometriosis and no abnormal ultrasound findings at initial examination develop endometriosis lesions or adenomyosis visible at ultrasound examination at long-term follow-up.Met…
View article: OC19.01: Prediction of outcome in endometrial cancer improved by combining traditional with sonographic and demographic parameters: IETA4 cohort follow‐up
OC19.01: Prediction of outcome in endometrial cancer improved by combining traditional with sonographic and demographic parameters: IETA4 cohort follow‐up Open
To develop and validate pre- and postoperative mathematical models to predict recurrence/progression of endometrial cancer, and to evaluate if these models outperform the ESMO/ESGO/ESTRO prognostic risk groups. All 1538 women in the prospe…
View article: EP30.02: Risk of malignancy in unilocular and multilocular adnexal masses according to ultrasound examination
EP30.02: Risk of malignancy in unilocular and multilocular adnexal masses according to ultrasound examination Open
Unilocular and multilocular adnexal masses of less than 100 mm have low risk of malignancy. However, the risk of malignancy is considered being increased if the mass is of ≥100 mm. The aim of this study was to define the risk of malignancy…
View article: OC19.02: Changes in the intensity of symptoms suggestive of endometriosis over time in women without abnormal findings at initial ultrasound examination
OC19.02: Changes in the intensity of symptoms suggestive of endometriosis over time in women without abnormal findings at initial ultrasound examination Open
Evaluate if changes in the intensity of dysmenorrhea and chronic pelvic pain at long-term follow-up in women without endometriosis findings at initial examination are associated with ultrasound findings of endometrioma, deep endometriosis …
View article: EP26.05: Prevalence of adenomyosis, as diagnosed at transvaginal ultrasound, in infertile women scheduled for their first assisted reproductive treatment
EP26.05: Prevalence of adenomyosis, as diagnosed at transvaginal ultrasound, in infertile women scheduled for their first assisted reproductive treatment Open
To determine the prevalence of direct and indirect features of adenomyosis, as defined by the revised Morphological Uterus Sonographic Assessment (MUSA) group, in infertile women. Infertile women aged 25–39 years, scheduled for their first…
View article: Prospective geographical and temporal validation of three published mathematical models to calculate risk of endometrial malignancy in patients with postmenopausal bleeding
Prospective geographical and temporal validation of three published mathematical models to calculate risk of endometrial malignancy in patients with postmenopausal bleeding Open
Full protocol available from the authors upon reasonable request. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content…
View article: Figure S2 from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models
Figure S2 from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models Open
Figure S2. Relationship between number of days between the two examinations and inter-observer difference in mean tumor diameter of benign and malignant tumors is shown on this scatterplot
View article: Figure S4 from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models
Figure S4 from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models Open
Figure S4. Relationship between number of days between the two examinations and inter-observer difference in mean diameter of the largest solid component in benign and malignant tumors is shown on this scatterplot
View article: Supplementary table S3 from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models
Supplementary table S3 from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models Open
Supplementary table S3. It describes which variables describing the adnexal masses differed between two observes when estimated risk was >25 percentage units using logistic regression model 2 (LR2)
View article: Supplementary table S2 from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models
Supplementary table S2 from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models Open
Supplementary table S2. It describes which variables describing the adnexal masses differed between two observes when estimated risk was >25 percentage units using logistic regression model 1 (LR1)
View article: Figure S1 from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models
Figure S1 from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models Open
Figure S1. Relationship between number of days between the two examinations and inter-observer difference in maximal tumor diameter of benign and malignant tumors is shown on this scatterplot
View article: Figure S3 from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models
Figure S3 from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models Open
Figure S3. Relationship between number of days between the two examinations and inter-observer difference in maximal diameter of the largest solid component in benign and malignant tumors is shown on this scatterplot
View article: Figure S4 from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models
Figure S4 from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models Open
Figure S4. Relationship between number of days between the two examinations and inter-observer difference in mean diameter of the largest solid component in benign and malignant tumors is shown on this scatterplot
View article: Figure S5 from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models
Figure S5 from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models Open
Figure S5. Relationship between number of days between the two examinations and inter-observer difference in height of the largest papillary projections in benign and malignant tumors is shown on this scatterplot
View article: Supplementary table S3 from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models
Supplementary table S3 from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models Open
Supplementary table S3. It describes which variables describing the adnexal masses differed between two observes when estimated risk was >25 percentage units using logistic regression model 2 (LR2)
View article: Data from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models
Data from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models Open
Purpose: To estimate interobserver agreement with regard to describing adnexal masses using the International Ovarian Tumor Analysis (IOTA) terminology and the risk of malignancy calculated using IOTA logistic regression models LR1 …
View article: Figure S2 from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models
Figure S2 from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models Open
Figure S2. Relationship between number of days between the two examinations and inter-observer difference in mean tumor diameter of benign and malignant tumors is shown on this scatterplot
View article: Supplementary table S2 from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models
Supplementary table S2 from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models Open
Supplementary table S2. It describes which variables describing the adnexal masses differed between two observes when estimated risk was >25 percentage units using logistic regression model 1 (LR1)
View article: Figure S3 from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models
Figure S3 from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models Open
Figure S3. Relationship between number of days between the two examinations and inter-observer difference in maximal diameter of the largest solid component in benign and malignant tumors is shown on this scatterplot
View article: Figure S5 from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models
Figure S5 from Interobserver Agreement in Describing the Ultrasound Appearance of Adnexal Masses and in Calculating the Risk of Malignancy Using Logistic Regression Models Open
Figure S5. Relationship between number of days between the two examinations and inter-observer difference in height of the largest papillary projections in benign and malignant tumors is shown on this scatterplot